MARBACH CARL B
Known title: DirectorCIK: 0001210655
Associated companies
Transaction History
| TOL | ▼ Sell | Open Market | 10,000 | $1.2M | 3/4/2024 | View on chart |
| TOL | ▲ Buy | Option Exercise | 3,003 | $0 | 1/20/2024 | View on chart |
| TOL | ▼ Sell | Open Market | 10,000 | $907K | 12/7/2023 | View on chart |
| TOL | ▲ Buy | Option Exercise | 3,694 | $130K | 9/1/2023 | View on chart |
| TOL | ▼ Sell | Open Market | 3,694 | $310K | 9/1/2023 | View on chart |
| TOL | ▼ Sell | Open Market | 2,000 | $157K | 7/5/2023 | View on chart |
| TOL | ▼ Sell | Open Market | 10,000 | $724K | 6/6/2023 | View on chart |
| TOL | ▼ Sell | Open Market | 2,000 | $119K | 4/11/2023 | View on chart |
| TOL | ▼ Sell | Open Market | 10,000 | $587K | 2/27/2023 | View on chart |
| TOL | ▲ Buy | Option Exercise | 3,911 | $0 | 1/20/2023 | View on chart |
| TOL | ▲ Buy | Option Exercise | 3,891 | $125K | 12/8/2022 | View on chart |
| TOL | ▼ Sell | Open Market | 3,891 | $192K | 12/8/2022 | View on chart |
| TOL | ▼ Sell | Open Market | 1,000 | $45K | 10/11/2022 | View on chart |
| TOL | ▲ Buy | Option Exercise | 4,725 | $0 | 1/18/2022 | View on chart |
| TOL | ▼ Sell | Open Market | 10,000 | $723K | 12/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Morgan Stanley initiates Toll Brothers coverage with Overweight rating
Morgan Stanley began covering Toll Brothers with an Overweight rating and a $159 price target. The firm positioned the homebuilder favorably compared to Berkshire Hathaway's preferred peers. This analyst action adds to a broader group of initiations reported this week, providing fresh institutional perspective on the stock.
Morgan Stanley initiates Toll Brothers coverage with Overweight rating. Morgan Stanley began covering Toll Brothers with an Overweight rating and a $159 price target. The firm positioned the homebuilder favorably compared to Berkshire Hathaway's preferred peers. This analyst action adds to a broader group of initiations reported this week, providing fresh institutional perspective on the stock.